Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury

Priya Ravikumar, Jyothi U. Menon, Primana Punnakitikashem, Dipendra Gyawali, Osamu Togao, Masaya Takahashi, Jianning Zhang, Jianfeng Ye, Orson W. Moe, Kytai T. Nguyen, Connie C.W. Hsia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Our goals were to develop and establish nanoparticle (NP)-facilitated inhalational gene delivery, and to validate its biomedical application by testing the hypothesis that targeted upregulation of pulmonary erythropoietin receptor (EpoR) expression protects against lung injury. Poly-lactic-co-glycolic acid (PLGA) NPs encapsulating various tracers were characterized and nebulizated into rat lungs. Widespread NP uptake and distribution within alveolar cells were visualized by magnetic resonance imaging, and fluorescent and electron microscopy. Inhalation of nebulized NPs bearing EpoR cDNA upregulated pulmonary EpoR expression and downstream signal transduction (ERK1/2 and STAT5 phosphorylation) in rats for up to 21 days, and attenuated hyperoxia-induced damage in lung tissue based on apoptosis, oxidative damage of DNA, protein and lipid, tissue edema, and alveolar morphology compared to vector-treated control animals. These results establish the feasibility and therapeutic efficacy of NP-facilitated cDNA delivery to the lung, and demonstrate that targeted pulmonary EpoR upregulation mitigates acute oxidative lung damage.

Original languageEnglish
Pages (from-to)811-821
Number of pages11
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume12
Issue number3
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Erythropoietin Receptors
Lung Injury
Nanoparticles
Complementary DNA
Lung
Rats
Bearings (structural)
Tissue
Signal transduction
Phosphorylation
Cell death
Magnetic resonance
Lipids
Electron microscopy
Animals
DNA
Genes
Up-Regulation
Proteins
Imaging techniques

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury. / Ravikumar, Priya; Menon, Jyothi U.; Punnakitikashem, Primana; Gyawali, Dipendra; Togao, Osamu; Takahashi, Masaya; Zhang, Jianning; Ye, Jianfeng; Moe, Orson W.; Nguyen, Kytai T.; Hsia, Connie C.W.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 12, No. 3, 01.04.2016, p. 811-821.

Research output: Contribution to journalArticle

Ravikumar, P, Menon, JU, Punnakitikashem, P, Gyawali, D, Togao, O, Takahashi, M, Zhang, J, Ye, J, Moe, OW, Nguyen, KT & Hsia, CCW 2016, 'Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 12, no. 3, pp. 811-821. https://doi.org/10.1016/j.nano.2015.10.004
Ravikumar, Priya ; Menon, Jyothi U. ; Punnakitikashem, Primana ; Gyawali, Dipendra ; Togao, Osamu ; Takahashi, Masaya ; Zhang, Jianning ; Ye, Jianfeng ; Moe, Orson W. ; Nguyen, Kytai T. ; Hsia, Connie C.W. / Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2016 ; Vol. 12, No. 3. pp. 811-821.
@article{32936dbace74454e990b24406126a3ee,
title = "Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury",
abstract = "Our goals were to develop and establish nanoparticle (NP)-facilitated inhalational gene delivery, and to validate its biomedical application by testing the hypothesis that targeted upregulation of pulmonary erythropoietin receptor (EpoR) expression protects against lung injury. Poly-lactic-co-glycolic acid (PLGA) NPs encapsulating various tracers were characterized and nebulizated into rat lungs. Widespread NP uptake and distribution within alveolar cells were visualized by magnetic resonance imaging, and fluorescent and electron microscopy. Inhalation of nebulized NPs bearing EpoR cDNA upregulated pulmonary EpoR expression and downstream signal transduction (ERK1/2 and STAT5 phosphorylation) in rats for up to 21 days, and attenuated hyperoxia-induced damage in lung tissue based on apoptosis, oxidative damage of DNA, protein and lipid, tissue edema, and alveolar morphology compared to vector-treated control animals. These results establish the feasibility and therapeutic efficacy of NP-facilitated cDNA delivery to the lung, and demonstrate that targeted pulmonary EpoR upregulation mitigates acute oxidative lung damage.",
author = "Priya Ravikumar and Menon, {Jyothi U.} and Primana Punnakitikashem and Dipendra Gyawali and Osamu Togao and Masaya Takahashi and Jianning Zhang and Jianfeng Ye and Moe, {Orson W.} and Nguyen, {Kytai T.} and Hsia, {Connie C.W.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.nano.2015.10.004",
language = "English",
volume = "12",
pages = "811--821",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury

AU - Ravikumar, Priya

AU - Menon, Jyothi U.

AU - Punnakitikashem, Primana

AU - Gyawali, Dipendra

AU - Togao, Osamu

AU - Takahashi, Masaya

AU - Zhang, Jianning

AU - Ye, Jianfeng

AU - Moe, Orson W.

AU - Nguyen, Kytai T.

AU - Hsia, Connie C.W.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Our goals were to develop and establish nanoparticle (NP)-facilitated inhalational gene delivery, and to validate its biomedical application by testing the hypothesis that targeted upregulation of pulmonary erythropoietin receptor (EpoR) expression protects against lung injury. Poly-lactic-co-glycolic acid (PLGA) NPs encapsulating various tracers were characterized and nebulizated into rat lungs. Widespread NP uptake and distribution within alveolar cells were visualized by magnetic resonance imaging, and fluorescent and electron microscopy. Inhalation of nebulized NPs bearing EpoR cDNA upregulated pulmonary EpoR expression and downstream signal transduction (ERK1/2 and STAT5 phosphorylation) in rats for up to 21 days, and attenuated hyperoxia-induced damage in lung tissue based on apoptosis, oxidative damage of DNA, protein and lipid, tissue edema, and alveolar morphology compared to vector-treated control animals. These results establish the feasibility and therapeutic efficacy of NP-facilitated cDNA delivery to the lung, and demonstrate that targeted pulmonary EpoR upregulation mitigates acute oxidative lung damage.

AB - Our goals were to develop and establish nanoparticle (NP)-facilitated inhalational gene delivery, and to validate its biomedical application by testing the hypothesis that targeted upregulation of pulmonary erythropoietin receptor (EpoR) expression protects against lung injury. Poly-lactic-co-glycolic acid (PLGA) NPs encapsulating various tracers were characterized and nebulizated into rat lungs. Widespread NP uptake and distribution within alveolar cells were visualized by magnetic resonance imaging, and fluorescent and electron microscopy. Inhalation of nebulized NPs bearing EpoR cDNA upregulated pulmonary EpoR expression and downstream signal transduction (ERK1/2 and STAT5 phosphorylation) in rats for up to 21 days, and attenuated hyperoxia-induced damage in lung tissue based on apoptosis, oxidative damage of DNA, protein and lipid, tissue edema, and alveolar morphology compared to vector-treated control animals. These results establish the feasibility and therapeutic efficacy of NP-facilitated cDNA delivery to the lung, and demonstrate that targeted pulmonary EpoR upregulation mitigates acute oxidative lung damage.

UR - http://www.scopus.com/inward/record.url?scp=84960116750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960116750&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2015.10.004

DO - 10.1016/j.nano.2015.10.004

M3 - Article

C2 - 26518603

AN - SCOPUS:84960116750

VL - 12

SP - 811

EP - 821

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 3

ER -